...
首页> 外文期刊>Tissue engineering, Part A >Stromal Cell-derived Factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro
【24h】

Stromal Cell-derived Factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro

机译:基质细胞衍生因子-1β在体外增强基因工程骨髓衍生间充质干细胞的骨形态发生蛋白-2刺激的骨诱导

获取原文
获取原文并翻译 | 示例
           

摘要

Skeletal injuries are among the most prevalent clinical problems and bone marrow-derived mesenchymal stem/stromal cells (BMSCs) have successfully been used for the treatment thereof. Stromal cell-derived factor-1 (SDF-1; CXCL12) is a member of the CXC chemokine family with multiple splice variants. The two most abundant variants, SDF-1α and SDF-1β, share identical amino acid sequences, except for four additional amino acids at the C-terminus of SDF-1β, which may mediate surface stabilization via glycosaminoglycans and protect SDF-1β from proteolytic cleavage, rendering it twice as potent as SDF-1α. Increasing evidence suggests that SDF-1 is involved in bone formation through regulation of recruitment, engraftment, proliferation, and differentiation of stem/progenitor cells. The underlying molecular mechanisms, however, have not yet been fully elucidated. In this study, we tested the hypothesis that SDF-1β can potentiate bone morphogenetic protein-2 (BMP-2)-stimulated osteogenic differentiation and chemotaxis of BMSCs in vitro. Utilizing retrovirus-mediated gene transfer to generate novel Tet-Off-SDF-1β BMSCs, we found that conditional SDF-1β expression is tightly regulated by doxycycline in a dose-dependent and temporal fashion, leading to significantly increased SDF-1β mRNA and protein levels. In addition, SDF-1β was found to enhance BMP-2-stimulated mineralization, mRNA and protein expression of key osteogenic markers, and regulate BMP-2 signal transduction via extracellular signal-regulated kinases 1/2 (Erk1/2) phosphorylation in genetically engineered BMSCs in vitro. We also showed that SDF-1β promotes the migratory response of CXC chemokine receptor 4 (CXCR4)-expressing BMSCs in vitro. Taken together, these data support that SDF-1β can play an important role in BMP-2-stimulated osteogenic differentiation of BMSCs and may exert its biological activity in both an autocrine and paracrine fashion.
机译:骨骼损伤是最普遍的临床问题之一,并且骨髓来源的间充质干/基质细胞(BMSC)已成功用于治疗。基质细胞衍生因子-1(SDF-1; CXCL12)是具有多个剪接变体的CXC趋化因子家族的成员。两个最丰富的变体SDF-1α和SDF-1β共享相同的氨基酸序列,但SDF-1β的C末端还有四个氨基酸,它们可以通过糖胺聚糖介导表面稳定作用并保护SDF-1β免受蛋白水解作用裂解,使其效力是SDF-1α的两倍。越来越多的证据表明,SDF-1通过调节干细胞/祖细胞的募集,植入,增殖和分化来参与骨形成。然而,尚未完全阐明潜在的分子机制。在这项研究中,我们测试了SDF-1β可以在体外增强骨形态发生蛋白2(BMP-2)刺激的B​​MSCs成骨分化和趋化性的假设。利用逆转录病毒介导的基因转移产生新型的Tet-Off-SDF-1βBMSC,我们发现强力霉素对条件性SDF-1β的表达具有剂量依赖性和时间依赖性,导致SDF-1βmRNA和蛋白质显着增加。水平。此外,发现SDF-1β可增强BMP-2刺激的矿化作用,关键成骨标记物的mRNA和蛋白表达,并通过细胞外信号调节激酶1/2(Erk1 / 2)磷酸化来调节BMP-2信号转导。体外设计的BMSC。我们还表明,SDF-1β在体外可促进表达CXC趋化因子受体4(CXCR4)的BMSC的迁移反应。综上所述,这些数据支持SDF-1β在BMP-2刺激的BMSCs成骨分化中起重要作用,并可能以自分泌和旁分泌方式发挥其生物学活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号